Your shopping cart is currently empty

Scyliorhinin I is an agonist for both neurokinin-1 (NK-1) and neurokinin-2 (NK-2) receptors, exhibiting a Ki value of 0.9 nM at rat submandibular gland NK-1 receptors and 2 nM at hamster bladder NK-2 receptors. Additionally, it possesses the capability to contract the longitudinal muscle of the guinea pig ileum.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Scyliorhinin I is an agonist for both neurokinin-1 (NK-1) and neurokinin-2 (NK-2) receptors, exhibiting a Ki value of 0.9 nM at rat submandibular gland NK-1 receptors and 2 nM at hamster bladder NK-2 receptors. Additionally, it possesses the capability to contract the longitudinal muscle of the guinea pig ileum. |
| Targets&IC50 | NK-2 (guinea pig):2 nM (Ki), NK1 (rat):0.9 nM (Ki) |
| Molecular Weight | 1218.47 |
| Formula | C59H87N13O13S |
| Cas No. | 103425-21-4 |
| Smiles | [C@H](CC1=CC=CC=C1)(C(N[C@@H](CC2=CC=C(O)C=C2)C(NCC(N[C@H](C(N[C@@H](CCSC)C(N)=O)=O)CC(C)C)=O)=O)=O)NC([C@@H](NC([C@@H](NC([C@H](CC3=CC=CC=C3)NC([C@H](CCCCN)NC([C@H](C)N)=O)=O)=O)CC(O)=O)=O)CCCCN)=O |
| Sequence | H-Ala-Lys-Phe-Asp-Lys-Phe-Tyr-Gly-Leu-Met-NH2 |
| Sequence Short | AKFDKFYGLM |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.